Skip to main content

 8US0 | pdb_00008us0

Human antibody S8V1-157 in complex with the A/American black duck/New Brunswick/00464/2010(H4N6) HA head domain


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.70 Å
  • R-Value Free: 
    0.293 (Depositor), 0.283 (DCC) 
  • R-Value Work: 
    0.246 (Depositor), 0.242 (DCC) 
  • R-Value Observed: 
    0.248 (Depositor) 

Starting Models: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8US0

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history. 

Literature

A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface.

Simmons, H.C., Finney, J., Kotaki, R., Adachi, Y., Park Moseman, A., Watanabe, A., Song, S., Robinson-McCarthy, L.R., Le Sage, V., Kuraoka, M., Moseman, E.A., Kelsoe, G., Takahashi, Y., McCarthy, K.R.

(2024) bioRxiv 

  • DOI: https://doi.org/10.1101/2023.12.13.571543
  • Primary Citation Related Structures: 
    8US0

  • PubMed Abstract: 

    Influenza infection and vaccination impart strain-specific immunity that protects against neither seasonal antigenic variants nor the next pandemic. However, antibodies directed to conserved sites can confer broad protection. Here we identify and characterize a class of human antibodies that engage a previously undescribed, conserved epitope on the influenza hemagglutinin (HA) protein. Prototype antibody S8V1-157 binds at the normally occluded interface between the HA head and stem. Antibodies to this HA head-stem interface epitope are non-neutralizing in vitro but protect against lethal influenza infection in mice. Antibody isotypes that direct clearance of infected cells enhance this protection. Head-stem interface antibodies bind to most influenza A serotypes and seasonal human variants, and are present at low frequencies in the memory B cell populations of multiple human donors. Vaccines designed to elicit these antibodies might contribute to "universal" influenza immunity.


  • Organizational Affiliation: 
    • Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Macromolecule Content 

  • Total Structure Weight: 494.58 kDa 
  • Atom Count: 33,101 
  • Modeled Residue Count: 4,244 
  • Deposited Residue Count: 4,464 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Hemagglutinin292Influenza A virusMutation(s): 0 
Gene Names: HA
UniProt
Find proteins for M1UPL4 (Influenza A virus)
Explore M1UPL4 
Go to UniProtKB:  M1UPL4
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupM1UPL4
Glycosylation
Glycosylation Sites: 2
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
human antibody S8V1-157 light chain221Homo sapiensMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
human antibody S8V1-157 heavy chain231Homo sapiensMutation(s): 0 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence

Oligosaccharides

Help  
Entity ID: 4
MoleculeChains Length2D Diagram GlycosylationD Interactions
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
AA [auth a],
CA [auth c],
S,
T,
U,
AA [auth a],
CA [auth c],
S,
T,
U,
V,
W,
X
3N-Glycosylation
Glycosylation Resources
GlyTouCan: G15407YE
GlyCosmos: G15407YE
GlyGen: G15407YE
Entity ID: 5
MoleculeChains Length2D Diagram GlycosylationD Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranoseBA [auth b],
Y,
Z
2N-Glycosylation
Glycosylation Resources
GlyTouCan: G42666HT
GlyCosmos: G42666HT
GlyGen: G42666HT

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
HA [auth M]2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
MES

Query on MES



Download:Ideal Coordinates CCD File
DA [auth A]
EA [auth D]
FA [auth G]
GA [auth J]
IA [auth M]
DA [auth A],
EA [auth D],
FA [auth G],
GA [auth J],
IA [auth M],
JA [auth P]
2-(N-MORPHOLINO)-ETHANESULFONIC ACID
C6 H13 N O4 S
SXGZJKUKBWWHRA-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.70 Å
  • R-Value Free:  0.293 (Depositor), 0.283 (DCC) 
  • R-Value Work:  0.246 (Depositor), 0.242 (DCC) 
  • R-Value Observed: 0.248 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 127.92α = 90
b = 241.54β = 101.619
c = 144.13γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PHENIXrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United States2P01AI089618-11A1

Revision History  (Full details and data files)

  • Version 1.0: 2024-10-30
    Type: Initial release
  • Version 1.1: 2025-08-06
    Changes: Database references